Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
Clinical trial NCT04157478 · UNKNOWN
Trial details
- NCT number
- NCT04157478
- Sponsor
- People's Hospital of Guangxi Zhuang Autonomous Region
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2022-12-01
- Enrollment
- 464
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.